The Latest Breaking News from Alkermes

On St. Patrick's Day, PDD Holdings and Aon lead five stocks near buy points that are at least a "little Irish."

A Relative Strength Rating upgrade for Alkermes shows improving technical performance.

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Alkermes stock plummeted to its lowest price since last December on disappointing test results for its experimental narcolepsy treatment.

Owing to the critical medical needs, the lookout for new technologies to deal with future advancements is at its peak. Breakthrough innovations, revolutionary treatments, and a booming industry align to make biotech stocks a potential goldmine for savvy investors. Therefore, it could be wise to invest in quality biotech stocks…

Strong recent economic data and still-elevated inflation are expected to keep the Fed on track for another interest rate hike next month. With the stock market likely to remain volatile amid rising interest rates and other macro uncertainties, fundamentally sound stocks Astellas (ALPMY), Alkermes (ALKS), and AstroNova (ALOT), trading at…

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

A Relative Strength Rating upgrade for Alkermes shows improving technical performance.

Seattle Genetics and Alkermes beat fourth-quarter estimates Thursday, pushing Alkermes stock into a brief breakout as SGEN stock soared.